Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism

Adv Neurol. 1999:80:129-33.
No abstract available

MeSH terms

  • Animals
  • Dyskinesia, Drug-Induced / physiopathology*
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Levodopa / adverse effects*
  • Male
  • Parkinson Disease, Secondary / drug therapy*
  • Piperazines / therapeutic use*
  • Quinoxalines / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glutamate / physiology*
  • Rotation
  • Stereotyped Behavior / drug effects
  • Stereotyped Behavior / physiology
  • Time Factors

Substances

  • Excitatory Amino Acid Antagonists
  • Piperazines
  • Quinoxalines
  • Receptors, Glutamate
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • Levodopa
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid